Glioma Supra Marginal Incision Trial

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
G-SUMIT is a pilot, phase II,randomized controlled trial to evaluate the feasibility of performing a large-scale trial in patients undergoing surgery for first-time diagnosis of high grade glioma (HGG) in a surgically favorable anatomical location to answer the following: Does extending the margin of resection 1 cm beyond visible enhanced volume on MRI result in (a) an increase in overall survival? (b) result in a similar rate of \"clinically-significant\" neurological worsening during 30 days post surgery and quality of life at 6 and 12 months?
Epistemonikos ID: 249fc14f9cd9a1454894f53e6450d5cb3fdd9af9
First added on: May 08, 2024